Phosphatidylserine containing omega-3 fatty acids may improve memory abilities in nondemented elderly individuals with memory complaints: Results from an open-label extension study

Dementia and Geriatric Cognitive Disorders

Volumn 38, Issue 1-2, 2014, Pages 39-45

  Vakhapova, Veronika ^a   Cohen, Tzafra ^c   Richter, Yael ^c   Herzog, Yael ^c   Kam, Yossi ^c   Korczyn, Amos D ^b  

^a MACCABI HEALTHCARE SERVICES   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c Enzymotec Ltd   (Israel)

Author keywords

Cognitive decline; Docosahexaenoic acid; Memory complaints; Omega 3 fatty acids; Phosphatidylserine

Indexed keywords

DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; PHOSPHATIDYLSERINE; PHOSPHATIDYLSERINE ENRICHED WITH DOCOSAHEXAENOIC ACID; PLACEBO; UNCLASSIFIED DRUG; VAYACOG; DRUG COMBINATION; NOOTROPIC AGENT; OMEGA 3 FATTY ACID;

AGED; ARTICLE; ATTENTION; CLINICAL ASSESSMENT TOOL; CLINICAL GLOBAL IMPRESSION SCALE; COGNITION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; MALE; MEMORY; MENTAL PERFORMANCE; MINI MENTAL STATE EXAMINATION; NORMAL HUMAN; OPEN STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECALL; RECOGNITION; SHORT TERM MEMORY; SIDE EFFECT; SPATIAL LEARNING; TENESMUS; TREATMENT DURATION; WEIGHT GAIN; DRUG COMBINATION; DRUG EFFECTS; DRUG MONITORING; GERIATRIC ASSESSMENT; MEMORY DISORDERS; NEUROPSYCHOLOGICAL TEST; PROCEDURES; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; TREATMENT OUTCOME; DRUG INDUCED HEADACHE; MAJOR CLINICAL STUDY; MEDICATION COMPLIANCE; MEMORY DISORDER;

AGED; ATTENTION; DOCOSAHEXAENOIC ACIDS; DRUG COMBINATIONS; DRUG MONITORING; FEMALE; GERIATRIC ASSESSMENT; HUMANS; MALE; MEMORY; MEMORY DISORDERS; NEUROPSYCHOLOGICAL TESTS; NOOTROPIC AGENTS; PHOSPHATIDYLSERINES; PSYCHIATRIC STATUS RATING SCALES; TREATMENT OUTCOME;

EID: 84895659025     PISSN: 14208008     EISSN: 14219824     Source Type: Journal    
DOI: 10.1159/000357793     Document Type: Article

References (25)

1. Vance JE, Steenbergen R: Metabolism and functions of phosphatidylserine. Prog Lipid Res 2005; 44: 207-234
2. Mozzi R, Buratta S, Goracci G: Metabolism and functions of phosphatidylserine in mammalian brain. Neurochem Res 2003; 28: 195-214
3. Yehuda S, Rabinovitz S, Carasso RL, Mostofsky DI: The role of polyunsaturated fatty acids in restoring the aging neuronal membrane. Neurobiol Aging 2002; 23: 843-853
4. Turner J: Your brain on food: a nutrient-rich diet can protect cognitive health. Generations 2011; 35: 99-116
5. Kosicek M, Hecimovic S: Phospholipids and Alzheimer's disease: alterations, mechanisms and potential biomarkers. Int J Mol Sci 2013; 14: 1310-1322
6. Cenacchi T, Bertoldin T, Farina C, Fiori MG, Crepaldi G: Cognitive decline in the elderly: a double-blind, placebocontrolled multicenter study on efficacy of phosphatidylserine administration. Aging 1993; 5: 123-133
7. Crook T, Petrie W, Wells C, Massari DC: Effects of phosphatidylserine in Alzheimer's disease. Psychopharmacol Bull 1992; 28: 61-66
8. Crook TH, Tinklenberg J, Yesavage J, Petrie W, Nunzi MG, Massari DC: Effects of phosphatidylserine in ageassociated memory impairment. Neurology 1991; 41: 644-649
9. Kim HY, Akbar M, Kim YS: Phosphatidylserine-dependent neuroprotective signaling promoted by docosahexaenoic acid. Prostaglandins Leukot Essent Fatty Acids 2010; 82: 165-172
10. Schreiber S, Kampf-Sherf O, Gorfine M, Kelly D, Oppenheim Y, Lerer B: An open trial of plant-source derived phosphatydilserine for treatment of age-related cognitive decline. Isr J Psychiatry Relat Sci 2000; 37: 302-307
11. Jorissen BL, Brouns F, Van Boxtel MP, Ponds RW, Verhey FR, Jolles J, Riedel WJ: The influence of soy-derived phosphatidylserine on cognition in age-associated memory impairment. Nutr Neurosci 2001; 4: 121-134
12. Vakhapova V, Cohen T, Richter Y, Herzog Y, Korczyn AD: Phosphatidylserine containing omega-3 fatty acids may improve memory abilities in non-demented elderly with memory complaints: a double-blind placebocontrolled trial. Dement Geriatr Cogn Disord 2010; 29: 467-474
13. Vakhapova V, Richter Y, Cohen T, Herzog Y, Korczyn AD: Safety of phosphatidylserine containing omega-3 fatty acids in non-demented elderly: a double-blind placebo-controlled trial followed by an open-label extension. BMC Neurol 2011; 11: 79
14. Aharonson V, Korczyn AD: Human-computer interaction in the administration and analysis of neuropsychological tests. Comput Methods Programs Biomed 2004; 73: 43-53
15. Dvoriantchikova G, Agudelo C, Hernandez E, Shestopalov VI, Ivanov D: Phosphatidylserine-containing liposomes promote maximal survival of retinal neurons after ischemic injury. J Cereb Blood Flow Metab 2009; 29: 1755-1759
16. Hashioka S, Han YH, Fujii S, Kato T, Monji A, Utsumi H, Sawada M, Nakanishi H, Kanba S: Phosphatidylserine and phosphatidylcholine-containing liposomes inhibit amyloid beta and interferon-gamma-induced microglial activation. Free Radic Biol Med 2007; 42: 945-954
17. Bonetti AC, Bellini F, Calderini G, Galbiati E, Toffano G: Age-dependent changes in the mechanisms controlling prolactin secretion and phosphatidylinositol turnover in male rats: effect of phosphatidylserine. Neuroendocrinology 1987; 45: 123-129
18. Heiss WD, Kessler J, Mielke R, Szelies B, Herholz K: Long-term effects of phosphatidylserine, pyritinol, and cognitive training in Alzheimer's disease. A neuropsychological, EEG, and PET investigation. Dementia 1994; 5: 88-98
19. Blokland A, Honig W, Brouns F, Jolles J: Cognition-enhancing properties of subchronic phosphatidylserine (PS) treatment in middle-aged rats: comparison of bovine cortex PS with egg PS and soybean PS. Nutrition 1999; 15: 778-783
20. Amaducci L, Crook TH, Lippi A, Bracco L, Baldereschi M, Latorraca S, Piersanti P, Tesco G, Sorbi S: Use of phosphatidylserine in Alzheimer's disease. Ann NY Acad Sci 1991; 640: 245-249
21. Amaducci L: Phosphatidylserine in the treatment of Alzheimer's disease: results of a multicenter study. Psychopharmacol Bull 1988; 24: 130-134
22. Phosphatidylserine in the treatment of clinically diagnosed Alzheimer's disease. The SMID Group. J Neural Transm Suppl 1987; 24: 287-292
23. Casamenti F, Scali C, Pepeu G: Phosphatidylserine reverses the age-dependent decrease in cortical acetylcholine release: a microdialysis study. Eur J Pharmacol 1991; 194: 11-16
24. Calderini G, Aporti F, Bellini F, Bonetti AC, Teolato S, Zanotti A, Toffano G: Pharmacological effect of phosphatidylserine on age-dependent memory dysfunction. Ann NY Acad Sci 1985; 444: 504-506
25. Engel J Jr, Henry TR, Risinger MW, Sutherling WW, Chugani HT: PET in relation to intracranial electrode evaluations. Epilepsy Res Suppl 1992; 5: 111-120